Effect of Kokilaksh and Musta in Gathiya (Rheumatoid Arthritis)

A Pharmacognostical and Clinical study of Kokilaksh (Asteracantha longifolia Nees.) and Mustak (Cyperus rotundus Linn.) in Amavata W.S.R to Rheumatoid arthritis. - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/068485

Enrollment

Registered

2024-06-06

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvement

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age: between 20 to 65 years. 2.Patients willing to participate in clinical trial and Patients having any clinical signs and symptoms of amavata (R.A). 3.Pre diagnosed case of R.A. according to ACR/EULAR Criteria. 4.Patients will select from any sex, any religion, and any occupation, economic and educational status.

Exclusion criteria

Exclusion criteria: 1.Patient not willing to sign the consent form. 2.Pregnant woman and lactating mother. 3.Other disease such as paralysis, severe anaemia, infectious disease, sever cardiac problem, malignant cancer patients and recently surgically operated case.

Design outcomes

Primary

Measure	Time frame
Changes in biochemical investigation (RA FACTOR,CBC,ESR) and subjective parametersTimepoint: 60 DAYS	—

Secondary

Measure	Time frame
Changes in the subjective parametersTimepoint: 20 Days, 40 Days, 60 Days	—

Countries

India

Contacts

Public ContactDr Priyanka Saini

Madan Mohan Malviya Government Ayurved College

m.raj3011@gmail.com9460012476

Outcome results